A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-12

AUTHORS

Rosa Nguyen, Huiyun Wu, Stanley Pounds, Hiroto Inaba, Raul C. Ribeiro, David Cullins, Barbara Rooney, Teresa Bell, Norman J. Lacayo, Kenneth Heym, Barbara Degar, Deborah Schiff, William E. Janssen, Brandon Triplett, Ching-Hon Pui, Wing Leung, Jeffrey E. Rubnitz

ABSTRACT

Consolidation therapies for children with intermediate- or high-risk acute myeloid leukemia (AML) are urgently needed to achieve higher cure rates while limiting therapy-related toxicities. We determined if adoptive transfer of natural killer (NK) cells from haploidentical killer immunoglobulin-like receptor (KIR)-human leukocyte antigen (HLA)-mismatched donors may prolong event-free survival in children with intermediate-risk AML who were in first complete remission after chemotherapy. Patients received cyclophosphamide (Day - 7), fludarabine (Days - 6 through - 2), and subcutaneous interleukin-2 (Days - 1, 1, 3, 5, 7, and 9). Purified, unmanipulated NK cells were infused on Day 0, and NK cell chimerism and phenotyping from peripheral blood were performed on Days 7, 14, 21, and 28. As primary endpoint, the event-free survival was compared to a cohort of 55 patients who completed chemotherapy and were in first complete remission but did not receive NK cells. Donor NK cell kinetics were determined as secondary endpoints. Twenty-one patients (median age at diagnosis, 6.0 years [range, 0.1-15.3 years]) received a median of 12.5 × 106 NK cells/kg (range, 3.6-62.2 × 106 cells/kg) without major side effects. All but 3 demonstrated transient engraftment with donor NK cells (median peak donor chimerism, 4% [range, 0-43%]). KIR-HLA-mismatched NK cells expanded in 17 patients (81%) and contracted in 4 (19%). However, adoptive transfer of NK cells did not decrease the cumulative incidence of relapse (0.393 [95% confidence interval: 0.182-0.599] vs. 0.35 [0.209-0.495]; P = .556) and did not improve event-free (60.7 ± 10.9% vs. 69.1 ± 6.8%; P = .553) or overall survival (84.2 ± 8.5% vs. 79.1 ± 6.6%; P = .663) over chemotherapy alone. The lack of benefit may result from insufficient numbers and limited persistence of alloreactive donor NK cells but does not preclude its potential usefulness during other phases of therapy, or in combination with other immunotherapeutic agents. TRIAL REGISTRATION: www.clinicaltrials.gov , NCT00703820 . Registered 24 June 2008. More... »

PAGES

81

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s40425-019-0564-6

DOI

http://dx.doi.org/10.1186/s40425-019-0564-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1112896693

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30894213


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "St. Jude Children's Research Hospital", 
          "id": "https://www.grid.ac/institutes/grid.240871.8", 
          "name": [
            "Department of Oncology, St. Jude Children\u2019s Hospital, 262 Danny Thomas Place, 38105, Memphis, TN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nguyen", 
        "givenName": "Rosa", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "St. Jude Children's Research Hospital", 
          "id": "https://www.grid.ac/institutes/grid.240871.8", 
          "name": [
            "Department of Biostatistics, St. Jude Children\u2019s Hospital, Memphis, TN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wu", 
        "givenName": "Huiyun", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "St. Jude Children's Research Hospital", 
          "id": "https://www.grid.ac/institutes/grid.240871.8", 
          "name": [
            "Department of Biostatistics, St. Jude Children\u2019s Hospital, Memphis, TN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pounds", 
        "givenName": "Stanley", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "St. Jude Children's Research Hospital", 
          "id": "https://www.grid.ac/institutes/grid.240871.8", 
          "name": [
            "Department of Oncology, St. Jude Children\u2019s Hospital, 262 Danny Thomas Place, 38105, Memphis, TN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Inaba", 
        "givenName": "Hiroto", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "St. Jude Children's Research Hospital", 
          "id": "https://www.grid.ac/institutes/grid.240871.8", 
          "name": [
            "Department of Oncology, St. Jude Children\u2019s Hospital, 262 Danny Thomas Place, 38105, Memphis, TN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ribeiro", 
        "givenName": "Raul C.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "St. Jude Children's Research Hospital", 
          "id": "https://www.grid.ac/institutes/grid.240871.8", 
          "name": [
            "Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children\u2019s Hospital, Memphis, TN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cullins", 
        "givenName": "David", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "St. Jude Children's Research Hospital", 
          "id": "https://www.grid.ac/institutes/grid.240871.8", 
          "name": [
            "Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children\u2019s Hospital, Memphis, TN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rooney", 
        "givenName": "Barbara", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "St. Jude Children's Research Hospital", 
          "id": "https://www.grid.ac/institutes/grid.240871.8", 
          "name": [
            "Department of Oncology, St. Jude Children\u2019s Hospital, 262 Danny Thomas Place, 38105, Memphis, TN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bell", 
        "givenName": "Teresa", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Lucile Packard Children's Hospital", 
          "id": "https://www.grid.ac/institutes/grid.414123.1", 
          "name": [
            "Lucile Packard Children\u2019s Hospital and Stanford Cancer Center, Palo Alto, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lacayo", 
        "givenName": "Norman J.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cook Children's Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.413584.f", 
          "name": [
            "Cook Children\u2019s Medical Center, Fort Worth, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Heym", 
        "givenName": "Kenneth", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Dana\u2013Farber Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.65499.37", 
          "name": [
            "Dana-Farber Cancer Institute, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Degar", 
        "givenName": "Barbara", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Rady Children's Hospital-San Diego", 
          "id": "https://www.grid.ac/institutes/grid.286440.c", 
          "name": [
            "Rady Children\u2019s Hospital, San Diego, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schiff", 
        "givenName": "Deborah", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "St. Jude Children's Research Hospital", 
          "id": "https://www.grid.ac/institutes/grid.240871.8", 
          "name": [
            "Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children\u2019s Hospital, Memphis, TN, USA", 
            "Human Applications Laboratory, St. Jude Children\u2019s Research Hospital, Memphis, TN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Janssen", 
        "givenName": "William E.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "St. Jude Children's Research Hospital", 
          "id": "https://www.grid.ac/institutes/grid.240871.8", 
          "name": [
            "Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children\u2019s Hospital, Memphis, TN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Triplett", 
        "givenName": "Brandon", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "St. Jude Children's Research Hospital", 
          "id": "https://www.grid.ac/institutes/grid.240871.8", 
          "name": [
            "Department of Oncology, St. Jude Children\u2019s Hospital, 262 Danny Thomas Place, 38105, Memphis, TN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pui", 
        "givenName": "Ching-Hon", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "St. Jude Children's Research Hospital", 
          "id": "https://www.grid.ac/institutes/grid.240871.8", 
          "name": [
            "Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children\u2019s Hospital, Memphis, TN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Leung", 
        "givenName": "Wing", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "St. Jude Children's Research Hospital", 
          "id": "https://www.grid.ac/institutes/grid.240871.8", 
          "name": [
            "Department of Oncology, St. Jude Children\u2019s Hospital, 262 Danny Thomas Place, 38105, Memphis, TN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rubnitz", 
        "givenName": "Jeffrey E.", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1046/j.1365-2141.1997.1112925.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000437859"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2141.1997.1112925.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000437859"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2014.55.3628", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002290526"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-08-3712", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002731471"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2006-07-038687", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004793941"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.24.4590", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009308039"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-1-4939-3684-7_15", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010029028", 
          "https://doi.org/10.1007/978-1-4939-3684-7_15"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1703162", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014123446", 
          "https://doi.org/10.1038/sj.bmt.1703162"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/pbc.25555", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015372347"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1053-4296(03)00031-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017567845"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1053-4296(03)00031-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017567845"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(10)70090-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020396989"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2008-06-164103", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020650223"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nri1088", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027524231", 
          "https://doi.org/10.1038/nri1088"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nri1088", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027524231", 
          "https://doi.org/10.1038/nri1088"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2567.2007.02573.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032932312"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(00)03231-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033626909"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2014-07-592881", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041349128"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.1068440", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045850261"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2011-01-329508", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046817842"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/leu.2015.52", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050348498", 
          "https://doi.org/10.1038/leu.2015.52"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2004-07-2974", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052161772"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1146/annurev.immunol.20.092501.134942", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052474653"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2017-05-785659", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091330774"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2017-05-785659", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091330774"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-17-3196", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101039924"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-12", 
    "datePublishedReg": "2019-12-01", 
    "description": "Consolidation therapies for children with intermediate- or high-risk acute myeloid leukemia (AML) are urgently needed to achieve higher cure rates while limiting therapy-related toxicities. We determined if adoptive transfer of natural killer (NK) cells from haploidentical killer immunoglobulin-like receptor (KIR)-human leukocyte antigen (HLA)-mismatched donors may prolong event-free survival in children with intermediate-risk AML who were in first complete remission after chemotherapy. Patients received cyclophosphamide (Day -\u20097), fludarabine (Days -\u20096 through -\u20092), and subcutaneous interleukin-2 (Days -\u20091, 1, 3, 5, 7, and 9). Purified, unmanipulated NK cells were infused on Day 0, and NK cell chimerism and phenotyping from peripheral blood were performed on Days 7, 14, 21, and 28. As primary endpoint, the event-free survival was compared to a cohort of 55 patients who completed chemotherapy and were in first complete remission but did not receive NK cells. Donor NK cell kinetics were determined as secondary endpoints. Twenty-one patients (median age at diagnosis, 6.0\u2009years [range, 0.1-15.3\u2009years]) received a median of 12.5\u2009\u00d7\u2009106 NK cells/kg (range, 3.6-62.2\u2009\u00d7\u2009106 cells/kg) without major side effects. All but 3 demonstrated transient engraftment with donor NK cells (median peak donor chimerism, 4% [range, 0-43%]). KIR-HLA-mismatched NK cells expanded in 17 patients (81%) and contracted in 4 (19%). However, adoptive transfer of NK cells did not decrease the cumulative incidence of relapse (0.393 [95% confidence interval: 0.182-0.599] vs. 0.35 [0.209-0.495]; P\u2009=\u00a0.556) and did not improve event-free (60.7\u00a0\u00b1\u200910.9% vs. 69.1\u00a0\u00b1\u20096.8%; P\u00a0=\u2009.553) or overall survival (84.2\u00a0\u00b1\u20098.5% vs. 79.1\u00a0\u00b1\u20096.6%; P\u00a0=\u2009.663) over chemotherapy alone. The lack of benefit may result from insufficient numbers and limited persistence of alloreactive donor NK cells but does not preclude its potential usefulness during other phases of therapy, or in combination with other immunotherapeutic agents. TRIAL REGISTRATION: www.clinicaltrials.gov , NCT00703820 . Registered 24 June 2008.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s40425-019-0564-6", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2438833", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1049249", 
        "issn": [
          "2051-1426"
        ], 
        "name": "Journal for ImmunoTherapy of Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "7"
      }
    ], 
    "name": "A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia", 
    "pagination": "81", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "30a402908e81b8f9ad9dcd0d9b0535f09353a7df7a6df0f9576e63856144c3f9"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30894213"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101620585"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s40425-019-0564-6"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1112896693"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s40425-019-0564-6", 
      "https://app.dimensions.ai/details/publication/pub.1112896693"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T14:01", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000371_0000000371/records_130829_00000006.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs40425-019-0564-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s40425-019-0564-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s40425-019-0564-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s40425-019-0564-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s40425-019-0564-6'


 

This table displays all metadata directly associated to this object as RDF triples.

250 TRIPLES      21 PREDICATES      51 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s40425-019-0564-6 schema:about anzsrc-for:11
2 anzsrc-for:1107
3 schema:author N3b538daeb6024cb0b862647b1267535e
4 schema:citation sg:pub.10.1007/978-1-4939-3684-7_15
5 sg:pub.10.1038/leu.2015.52
6 sg:pub.10.1038/nri1088
7 sg:pub.10.1038/sj.bmt.1703162
8 https://doi.org/10.1002/pbc.25555
9 https://doi.org/10.1016/s0140-6736(00)03231-1
10 https://doi.org/10.1016/s1053-4296(03)00031-6
11 https://doi.org/10.1016/s1470-2045(10)70090-5
12 https://doi.org/10.1046/j.1365-2141.1997.1112925.x
13 https://doi.org/10.1111/j.1365-2567.2007.02573.x
14 https://doi.org/10.1126/science.1068440
15 https://doi.org/10.1146/annurev.immunol.20.092501.134942
16 https://doi.org/10.1158/0008-5472.can-08-3712
17 https://doi.org/10.1158/1078-0432.ccr-17-3196
18 https://doi.org/10.1182/blood-2004-07-2974
19 https://doi.org/10.1182/blood-2006-07-038687
20 https://doi.org/10.1182/blood-2008-06-164103
21 https://doi.org/10.1182/blood-2011-01-329508
22 https://doi.org/10.1182/blood-2014-07-592881
23 https://doi.org/10.1182/blood-2017-05-785659
24 https://doi.org/10.1200/jco.2009.24.4590
25 https://doi.org/10.1200/jco.2014.55.3628
26 schema:datePublished 2019-12
27 schema:datePublishedReg 2019-12-01
28 schema:description Consolidation therapies for children with intermediate- or high-risk acute myeloid leukemia (AML) are urgently needed to achieve higher cure rates while limiting therapy-related toxicities. We determined if adoptive transfer of natural killer (NK) cells from haploidentical killer immunoglobulin-like receptor (KIR)-human leukocyte antigen (HLA)-mismatched donors may prolong event-free survival in children with intermediate-risk AML who were in first complete remission after chemotherapy. Patients received cyclophosphamide (Day - 7), fludarabine (Days - 6 through - 2), and subcutaneous interleukin-2 (Days - 1, 1, 3, 5, 7, and 9). Purified, unmanipulated NK cells were infused on Day 0, and NK cell chimerism and phenotyping from peripheral blood were performed on Days 7, 14, 21, and 28. As primary endpoint, the event-free survival was compared to a cohort of 55 patients who completed chemotherapy and were in first complete remission but did not receive NK cells. Donor NK cell kinetics were determined as secondary endpoints. Twenty-one patients (median age at diagnosis, 6.0 years [range, 0.1-15.3 years]) received a median of 12.5 × 10<sup>6</sup> NK cells/kg (range, 3.6-62.2 × 10<sup>6</sup> cells/kg) without major side effects. All but 3 demonstrated transient engraftment with donor NK cells (median peak donor chimerism, 4% [range, 0-43%]). KIR-HLA-mismatched NK cells expanded in 17 patients (81%) and contracted in 4 (19%). However, adoptive transfer of NK cells did not decrease the cumulative incidence of relapse (0.393 [95% confidence interval: 0.182-0.599] vs. 0.35 [0.209-0.495]; P = .556) and did not improve event-free (60.7 ± 10.9% vs. 69.1 ± 6.8%; P = .553) or overall survival (84.2 ± 8.5% vs. 79.1 ± 6.6%; P = .663) over chemotherapy alone. The lack of benefit may result from insufficient numbers and limited persistence of alloreactive donor NK cells but does not preclude its potential usefulness during other phases of therapy, or in combination with other immunotherapeutic agents. TRIAL REGISTRATION: www.clinicaltrials.gov , NCT00703820 . Registered 24 June 2008.
29 schema:genre research_article
30 schema:inLanguage en
31 schema:isAccessibleForFree true
32 schema:isPartOf N677a5a8f5a37403e9ca0d19ef9cebab4
33 N7e99f031c0eb4bd5ade1004e4b817054
34 sg:journal.1049249
35 schema:name A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia
36 schema:pagination 81
37 schema:productId N2a19c84f72a742d9895bd5e39f586480
38 N4fabe514d1764873b2c0c77c399892bd
39 N52710d746ab94a3d9abdadbd0212eebe
40 Nb958205ebd2940a6919539bfe3f51fa6
41 Nf13fb0900a534052b8e5d03153786844
42 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112896693
43 https://doi.org/10.1186/s40425-019-0564-6
44 schema:sdDatePublished 2019-04-11T14:01
45 schema:sdLicense https://scigraph.springernature.com/explorer/license/
46 schema:sdPublisher N45a2c972164d40d1b1afae7987328376
47 schema:url https://link.springer.com/10.1186%2Fs40425-019-0564-6
48 sgo:license sg:explorer/license/
49 sgo:sdDataset articles
50 rdf:type schema:ScholarlyArticle
51 N022abfaceca54a1588f7767bb70a8e4c rdf:first N08fc98de0c3948c69f0d2185fe77935c
52 rdf:rest N32e10ea9c3dc4e12a698fe6e7d550169
53 N08fc98de0c3948c69f0d2185fe77935c schema:affiliation https://www.grid.ac/institutes/grid.65499.37
54 schema:familyName Degar
55 schema:givenName Barbara
56 rdf:type schema:Person
57 N10ac958100534e4eb3746c8bb674defe rdf:first N1e016fd44af2492dbbfe111e364d7d1c
58 rdf:rest N4e404721385a4d28ac4f3117ef4b009b
59 N11a3de389d4c40da95e47b94c3fdf5e2 rdf:first Nc875282d411a473db26f3b67ff2657e7
60 rdf:rest N2dc643a0cfb240a9adcafcfa98a5b506
61 N1e016fd44af2492dbbfe111e364d7d1c schema:affiliation https://www.grid.ac/institutes/grid.240871.8
62 schema:familyName Pounds
63 schema:givenName Stanley
64 rdf:type schema:Person
65 N2161d4bd33bf4e8684b51d29ed89735a schema:affiliation https://www.grid.ac/institutes/grid.286440.c
66 schema:familyName Schiff
67 schema:givenName Deborah
68 rdf:type schema:Person
69 N2679c0389b404021b03a11710f8fd2aa schema:affiliation https://www.grid.ac/institutes/grid.240871.8
70 schema:familyName Inaba
71 schema:givenName Hiroto
72 rdf:type schema:Person
73 N2a19c84f72a742d9895bd5e39f586480 schema:name dimensions_id
74 schema:value pub.1112896693
75 rdf:type schema:PropertyValue
76 N2dc643a0cfb240a9adcafcfa98a5b506 rdf:first N78186ee982f34b01bc5f4e26bc770569
77 rdf:rest N79b433a3c4e74683b1e77d6c9a5bb212
78 N32e10ea9c3dc4e12a698fe6e7d550169 rdf:first N2161d4bd33bf4e8684b51d29ed89735a
79 rdf:rest N6e79b2c8e7c347139629aec2deca34ad
80 N37741a212fa14feda6db53753e0d7464 schema:affiliation https://www.grid.ac/institutes/grid.240871.8
81 schema:familyName Bell
82 schema:givenName Teresa
83 rdf:type schema:Person
84 N3a24d54d23cc44e2bbef5ed67e04f933 rdf:first N76952599f28d47c98bc2ac7e75aa29be
85 rdf:rest N10ac958100534e4eb3746c8bb674defe
86 N3b538daeb6024cb0b862647b1267535e rdf:first Ne22ffe11ec2349648c7c01ec5e901552
87 rdf:rest N3a24d54d23cc44e2bbef5ed67e04f933
88 N45a2c972164d40d1b1afae7987328376 schema:name Springer Nature - SN SciGraph project
89 rdf:type schema:Organization
90 N464c8d3307224b0f8d366f9c3d684d7a rdf:first N90bceece34194cf5a09a79b4c2107d5c
91 rdf:rest Nbd95d7e0627c497da36a86cffbf175e4
92 N48c8307153ba48b9abe620e13cf8915d schema:affiliation https://www.grid.ac/institutes/grid.414123.1
93 schema:familyName Lacayo
94 schema:givenName Norman J.
95 rdf:type schema:Person
96 N4e404721385a4d28ac4f3117ef4b009b rdf:first N2679c0389b404021b03a11710f8fd2aa
97 rdf:rest Nc5eb15c181354360b07eaf97a0fef1ca
98 N4fabe514d1764873b2c0c77c399892bd schema:name pubmed_id
99 schema:value 30894213
100 rdf:type schema:PropertyValue
101 N50d76fe10287417a9bb8d5dfdee34c83 schema:affiliation https://www.grid.ac/institutes/grid.240871.8
102 schema:familyName Triplett
103 schema:givenName Brandon
104 rdf:type schema:Person
105 N52710d746ab94a3d9abdadbd0212eebe schema:name nlm_unique_id
106 schema:value 101620585
107 rdf:type schema:PropertyValue
108 N54227cb78e8740a99f0bac77bb3a0608 schema:affiliation https://www.grid.ac/institutes/grid.240871.8
109 schema:familyName Rubnitz
110 schema:givenName Jeffrey E.
111 rdf:type schema:Person
112 N677a5a8f5a37403e9ca0d19ef9cebab4 schema:issueNumber 1
113 rdf:type schema:PublicationIssue
114 N6e79b2c8e7c347139629aec2deca34ad rdf:first N9b6a47a8fb074128a7d11e9df0629b92
115 rdf:rest N832a2d7848f64fcd97c53626a21ff582
116 N76952599f28d47c98bc2ac7e75aa29be schema:affiliation https://www.grid.ac/institutes/grid.240871.8
117 schema:familyName Wu
118 schema:givenName Huiyun
119 rdf:type schema:Person
120 N78186ee982f34b01bc5f4e26bc770569 schema:affiliation https://www.grid.ac/institutes/grid.240871.8
121 schema:familyName Rooney
122 schema:givenName Barbara
123 rdf:type schema:Person
124 N79b433a3c4e74683b1e77d6c9a5bb212 rdf:first N37741a212fa14feda6db53753e0d7464
125 rdf:rest N9b3573ffa5074d13bd4fb38cf7743e4d
126 N7e99f031c0eb4bd5ade1004e4b817054 schema:volumeNumber 7
127 rdf:type schema:PublicationVolume
128 N832a2d7848f64fcd97c53626a21ff582 rdf:first N50d76fe10287417a9bb8d5dfdee34c83
129 rdf:rest N464c8d3307224b0f8d366f9c3d684d7a
130 N90bceece34194cf5a09a79b4c2107d5c schema:affiliation https://www.grid.ac/institutes/grid.240871.8
131 schema:familyName Pui
132 schema:givenName Ching-Hon
133 rdf:type schema:Person
134 N94c95e38927e4933b3fefd8e6ef2339c schema:affiliation https://www.grid.ac/institutes/grid.413584.f
135 schema:familyName Heym
136 schema:givenName Kenneth
137 rdf:type schema:Person
138 N95c4806af8d94886866e8605ab51d338 schema:affiliation https://www.grid.ac/institutes/grid.240871.8
139 schema:familyName Ribeiro
140 schema:givenName Raul C.
141 rdf:type schema:Person
142 N98615220083948e3b6b32d1effa9ff91 schema:affiliation https://www.grid.ac/institutes/grid.240871.8
143 schema:familyName Leung
144 schema:givenName Wing
145 rdf:type schema:Person
146 N9b3573ffa5074d13bd4fb38cf7743e4d rdf:first N48c8307153ba48b9abe620e13cf8915d
147 rdf:rest Ndaf7a7fb66404b67b2d7dd5898ce3eb5
148 N9b6a47a8fb074128a7d11e9df0629b92 schema:affiliation https://www.grid.ac/institutes/grid.240871.8
149 schema:familyName Janssen
150 schema:givenName William E.
151 rdf:type schema:Person
152 Nb2c23b1589da4cbfa1dbe759c05fa510 rdf:first N54227cb78e8740a99f0bac77bb3a0608
153 rdf:rest rdf:nil
154 Nb958205ebd2940a6919539bfe3f51fa6 schema:name doi
155 schema:value 10.1186/s40425-019-0564-6
156 rdf:type schema:PropertyValue
157 Nbd95d7e0627c497da36a86cffbf175e4 rdf:first N98615220083948e3b6b32d1effa9ff91
158 rdf:rest Nb2c23b1589da4cbfa1dbe759c05fa510
159 Nc5eb15c181354360b07eaf97a0fef1ca rdf:first N95c4806af8d94886866e8605ab51d338
160 rdf:rest N11a3de389d4c40da95e47b94c3fdf5e2
161 Nc875282d411a473db26f3b67ff2657e7 schema:affiliation https://www.grid.ac/institutes/grid.240871.8
162 schema:familyName Cullins
163 schema:givenName David
164 rdf:type schema:Person
165 Ndaf7a7fb66404b67b2d7dd5898ce3eb5 rdf:first N94c95e38927e4933b3fefd8e6ef2339c
166 rdf:rest N022abfaceca54a1588f7767bb70a8e4c
167 Ne22ffe11ec2349648c7c01ec5e901552 schema:affiliation https://www.grid.ac/institutes/grid.240871.8
168 schema:familyName Nguyen
169 schema:givenName Rosa
170 rdf:type schema:Person
171 Nf13fb0900a534052b8e5d03153786844 schema:name readcube_id
172 schema:value 30a402908e81b8f9ad9dcd0d9b0535f09353a7df7a6df0f9576e63856144c3f9
173 rdf:type schema:PropertyValue
174 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
175 schema:name Medical and Health Sciences
176 rdf:type schema:DefinedTerm
177 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
178 schema:name Immunology
179 rdf:type schema:DefinedTerm
180 sg:grant.2438833 http://pending.schema.org/fundedItem sg:pub.10.1186/s40425-019-0564-6
181 rdf:type schema:MonetaryGrant
182 sg:journal.1049249 schema:issn 2051-1426
183 schema:name Journal for ImmunoTherapy of Cancer
184 rdf:type schema:Periodical
185 sg:pub.10.1007/978-1-4939-3684-7_15 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010029028
186 https://doi.org/10.1007/978-1-4939-3684-7_15
187 rdf:type schema:CreativeWork
188 sg:pub.10.1038/leu.2015.52 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050348498
189 https://doi.org/10.1038/leu.2015.52
190 rdf:type schema:CreativeWork
191 sg:pub.10.1038/nri1088 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027524231
192 https://doi.org/10.1038/nri1088
193 rdf:type schema:CreativeWork
194 sg:pub.10.1038/sj.bmt.1703162 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014123446
195 https://doi.org/10.1038/sj.bmt.1703162
196 rdf:type schema:CreativeWork
197 https://doi.org/10.1002/pbc.25555 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015372347
198 rdf:type schema:CreativeWork
199 https://doi.org/10.1016/s0140-6736(00)03231-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033626909
200 rdf:type schema:CreativeWork
201 https://doi.org/10.1016/s1053-4296(03)00031-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017567845
202 rdf:type schema:CreativeWork
203 https://doi.org/10.1016/s1470-2045(10)70090-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020396989
204 rdf:type schema:CreativeWork
205 https://doi.org/10.1046/j.1365-2141.1997.1112925.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1000437859
206 rdf:type schema:CreativeWork
207 https://doi.org/10.1111/j.1365-2567.2007.02573.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1032932312
208 rdf:type schema:CreativeWork
209 https://doi.org/10.1126/science.1068440 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045850261
210 rdf:type schema:CreativeWork
211 https://doi.org/10.1146/annurev.immunol.20.092501.134942 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052474653
212 rdf:type schema:CreativeWork
213 https://doi.org/10.1158/0008-5472.can-08-3712 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002731471
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1158/1078-0432.ccr-17-3196 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101039924
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1182/blood-2004-07-2974 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052161772
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1182/blood-2006-07-038687 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004793941
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1182/blood-2008-06-164103 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020650223
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1182/blood-2011-01-329508 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046817842
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1182/blood-2014-07-592881 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041349128
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1182/blood-2017-05-785659 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091330774
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1200/jco.2009.24.4590 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009308039
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1200/jco.2014.55.3628 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002290526
232 rdf:type schema:CreativeWork
233 https://www.grid.ac/institutes/grid.240871.8 schema:alternateName St. Jude Children's Research Hospital
234 schema:name Department of Biostatistics, St. Jude Children’s Hospital, Memphis, TN, USA
235 Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children’s Hospital, Memphis, TN, USA
236 Department of Oncology, St. Jude Children’s Hospital, 262 Danny Thomas Place, 38105, Memphis, TN, USA
237 Human Applications Laboratory, St. Jude Children’s Research Hospital, Memphis, TN, USA
238 rdf:type schema:Organization
239 https://www.grid.ac/institutes/grid.286440.c schema:alternateName Rady Children's Hospital-San Diego
240 schema:name Rady Children’s Hospital, San Diego, CA, USA
241 rdf:type schema:Organization
242 https://www.grid.ac/institutes/grid.413584.f schema:alternateName Cook Children's Medical Center
243 schema:name Cook Children’s Medical Center, Fort Worth, TX, USA
244 rdf:type schema:Organization
245 https://www.grid.ac/institutes/grid.414123.1 schema:alternateName Lucile Packard Children's Hospital
246 schema:name Lucile Packard Children’s Hospital and Stanford Cancer Center, Palo Alto, CA, USA
247 rdf:type schema:Organization
248 https://www.grid.ac/institutes/grid.65499.37 schema:alternateName Dana–Farber Cancer Institute
249 schema:name Dana-Farber Cancer Institute, Boston, MA, USA
250 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...